Acerta Pharma

HealthcareSeries ANetherlandsacerta-pharma.com

Latest round

Series A

Last raised

Mar 2013

Total raised

Undisclosed

Investors

2

About Acerta Pharma

Acerta Pharma, founded by Ahmed Hamdy, specializes in hematology product development.5 billion for a 55 percent majority stake. Its headquarters is located in the Netherlands.Acerta Pharma specializes in developing innovative therapies for hematological malignancies, focusing on investigational agents that target cancer cells and boost the immune system's capacity to eliminate cancer. Their primary offerings include first-in-class and best-in-class medicines for various blood cancers, aimed at addressing significant unmet medical needs.81 mn. The company aims to launch several new products targeting blood cancers by 2025 and is focusing on expanding its presence in Asia and Europe. The acquisition in December 2015 will support these initiatives by providing the necessary capital for development and commercialization efforts.

Who invested in Acerta Pharma

2 investors across 1 round

See all investors in Acerta Pharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Mar 14, 2013

    Amount

    Undisclosed

    Investors

    Locked

Questions about Acerta Pharma

Who invested in Acerta Pharma?

Acerta Pharma has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Acerta Pharma raised?

Acerta Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Acerta Pharma last raise money?

Acerta Pharma's most recent round on record is a Series A, in Mar 2013.

What does Acerta Pharma do?

Acerta Pharma, founded by Ahmed Hamdy, specializes in hematology product development.

Where is Acerta Pharma headquartered?

Acerta Pharma is headquartered in Netherlands.

Which VCs invest in companies like Acerta Pharma?

Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at Acerta Pharma's stage. Their profiles are linked below.

Raising like Acerta Pharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.